Patient
SITE005-0273
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2026-07-28
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-03-11 (study day 40); relationship: RELATED
Grade 3 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-03-08 (study day 37); relationship: not assessed
Grade 3 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-03-07 (study day 36); relationship: NOT RELATED
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-03-01 (study day 30); relationship: not assessed; serious criteria: hospitalization
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-20 (study day 21); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.